Подходы Европейского Союза к регулированию клеточной терапии

Салагай Олег Олегович

doi:10.7256/2454-0706.2012.8.6536


	Journal Menu > Issues > Rubrics > About journal > Authors > About the Journal > Requirements for publication > Editorial board > Peer-review process > Policy of publication. Aims & Scope. > Article retraction > Ethics > Online First Pre-Publication > Copyright & Licensing Policy > Digital archiving policy > Open Access Policy > Article Processing Charge > Article Identification Policy > Plagiarism check policy > Editorial collegium


	Journals in science databases


	About the Journal

MAIN PAGE > Back to contents

Law and Politics

Reference:

Salagay O. // Law and Politics. 2012. № 8. DOI: 10.7256/2454-0706.2012.8.6536 URL: https://en.nbpublish.com/library_read_article.php?id=6536

Подходы Европейского Союза к регулированию клеточной терапии

Salagay Oleg

PhD in Medicine

Deputy Director, Department of International Cooperation and Public Relations, Ministry of Health of the Russian Federation

127994, Russia, Moscow, Pereulok Rakhmanovskiy 3

salagay@mail.ru

Other publications by this author

Article was published in rubric "INTEGRATION LAW AND SUPRANATIONAL UNIONS"

DOI:

10.7256/2454-0706.2012.8.6536

Received:

18-07-2012

Published:

1-8-2012

References

1. Anisimov S.V. Kletochnaya terapiya bolezni Parkinsona: II. Primenenie somaticheskih stvolovyh kletok. Uspehi Gerontologii. 2009. 22. №1. S.150-166.

2. Vasil'ev A.V. i soavt. Pravovye aspekty nauchnyh issledovaniy v oblasti razvitiya kletochnyh tehnologiy i vnedreniya ih v klinicheskuyu praktiku. Medicinskoe pravo. 2010. № 3. S. 9-14.

3. Koncevenko A.S. Pravovoe regulirovanie biomedicinskih issledovaniy i primeneniya novyh biotehnologiy v Evropeyskom Soyuze: Dis. … kand. yurid. nauk. M., 2011. 165 s.

4. Kravcov R. V., Karavaeva E. I. Biomedicinskie tehnologii: voprosy pravovogo regulirovaniya i otvetstvennosti. Sibirskiy yuridicheskiy vestnik. 2005. № 3. S. 7-12.

5. Salagay O.O. Obschie polozheniya prava Evropeyskogo Soyuza, primenimye k kletkam i tkanyam cheloveka. Medicinskoe pravo. 2011. № 5. S. 6-11.

6. Taras'yanc E.V. Mezhdunarodnaya zaschita i pooschrenie prav cheloveka v oblasti biomedicinskih issledovaniy: Dis. … kand. yurid. nauk. M., 2010. 197 s.

7. Sheverdin A.V. Sozdanie i ispol'zovanie biotehnologiy: istoriya voprosa. Zhurnal rossiyskogo prava. 2012. № 6. S. 118-126.

8. Bignami F. et al. Participation of patients in the development of advanced therapy medicinal products. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;54(7):839-42.

9. Buchholz C.J. et al.The European hospital exemption clause-new option for gene therapy? Hum Gene Ther. 2012 Jan;23(1):7-12.

10. Liu J. et al. Skin and oral mucosa equivalents: construction and performance. Orthod Craniofac Res. 2010 Feb;13(1):11-20.

11. Ra J.C. et al. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med. 2011 Oct 21;9:181.

12. Regenerative Medicine - A Global Strategic Business Report. Global Industry Analysts, Inc., 2010, 381 P.

13. Russ H.A., Efrat S. Development of human insulin-producing cells for cell therapy of diabetes. Pediatr Endocrinol Rev. 2011 Dec;9(2):590-7

14. Terskikh V.V., Vasiliev A.V. Cultivation and transplantation of epidermal keratinocytes. Int Rev Cytol. 1999;188:41-72.

15. Thomas E.D. et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 1957.257 (11). 491-496.

16. Van Wilder P. Advanced Therapy Medicinal Products and Exemptions to the Regulation 1394/2007: How Confident Can We be? An Exploratory Analysis. Front Pharmacol. 2012;3:12.

Link to this article

You can simply select and copy link from below text field.